0.02 (2.26%) 1d
Gritstone Oncology
A biotech that's up 342% in the past week, because yesterday they announced they're working on a 2nd-generation Covid vaccine. They already an agreement with the National Institute for Allergy and Infectious Diseases to start testing it. Their immunotherapy-based vaccine could be a game-changer even in phase 1 testing.
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Gritstone Oncology(GRTS-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Gritstone Oncology is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Gritstone Oncology(GRTS-Q) Frequently Asked Questions

What is Gritstone Oncology stock symbol?

Gritstone Oncology is a American stock, trading under the symbol GRTS-Q on the NASDAQ (GRTS). It is usually referred to as NASDAQ:GRTS or GRTS-Q

Is Gritstone Oncology a buy or a sell?

In the last year, there was no coverage of Gritstone Oncology published on Stockchase.

Is Gritstone Oncology a good investment or a top pick?

Gritstone Oncology was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Gritstone Oncology.

Why is Gritstone Oncology stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Gritstone Oncology worth watching?

In the last year 0 stock analysts on Stockchase covered Gritstone Oncology. The stock is worth watching.

What is Gritstone Oncology stock price?

On 2024-05-23, Gritstone Oncology (GRTS-Q) stock closed at a price of $0.8231.